Our editorial approach
We rely on primary sources, registries, peer-reviewed literature, and official guidance when available. Where claims are anecdotal, we label them as such and avoid treating personal reports as clinical evidence. For procedural clarity we cross-reference public registries and clinical summaries to flag inconsistencies.
Because regulatory frameworks and clinical practices evolve, we link to foundational overview resources when describing methods for sourcing and verification; for example, general principles of evidence synthesis are consistent with accepted practice described on reference sites like evidence-based medicine on Wikipedia.
What we cover
Our pages summarize the types of information people commonly seek: access pathways, clinic and practitioner transparency, safety checks, and travel considerations. We do not provide individualized care advice; instead, our materials aim to help readers find verifiable facts and ask informed questions of providers.
To see how broad program-level practices and safety frameworks are treated in other contexts, we sometimes reference authoritative health-policy resources such as governmental health portals like CDC guidance when discussing general safety assessment concepts.
How information is sourced and vetted
Sources include clinical registries, peer-reviewed studies, official health guidance, court or regulatory documents when accessible, and direct materials published by providers. We prioritize primary-source documentation and declare the provenance of data in each piece. Where systematic reviews exist we point readers toward them and note major limitations.
Our verification process references established transparency and citation practices similar to those taught in university research programs; readers may consult methodological overviews at institutions like Harvard University for general principles of source evaluation.
Editorial principles
- Independence: We do not accept funding that creates editorial conflicts of interest.
- Safety awareness: Information highlights safety practices and openly acknowledges known risks.
- Plain language: We prioritize clarity for non-specialist readers.
- Evidence before claims: Marketing statements are separated from verifiable facts.
- Informed choice: We present trade-offs so readers can make their own decisions.
Who this is for
This resource is for people considering ibogaine in Mexico, their families, and anyone seeking clear context on risks, regulation, and care standards. If you want a quick entry point to our site structure, our homepage describes the topical hubs and navigation pathways available across the project; see the site overview sentence that links directly back to the primary landing pages at the start of our site (site overview and navigation).
For readers seeking clinical services, our pages describe what to ask and which documentation to request; for more direct information about programs and listings we provide an annotated directory style entry and editorial notes in our Services section at Services and directory.
Caveats and disclosure
Cactus Lantern is an independent information resource and is not a clinic, medical provider, or licensed treatment center. Our content is not medical or legal advice. We aim to help readers distinguish marketing claims from evidence, safeguards, and unresolved risks.
We also monitor external knowledge hubs for policy and safety updates and quote public registries where relevant; for example, when discussing regulatory reporting we consult widely used clinical registry summaries and domain-specific resources such as ibogaine neuroregeneration resources to confirm program-level claims.